Company / Profit Margin
Arcutis Biotherapeutics, Inc. Profit Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-4.3%
FY2025
5-year range
-71.3% / -4.3%
FY2024-FY2025
Trend
+94.0%
vs FY2024
Sector context
#63 of 145
Health Care
What the data says
At -4.3%, Arcutis Biotherapeutics, Inc.'s profit margin ranks #63 of 145 in the Health Care sector.
Based on SEC 10-K filings.
-4.3% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#63 of 145 in Health CareTop 43% of 145This company -4.3% Sector average -792.7%
▼
+99.5% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 94.0% year-over-year.
- Currently 788.4pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4.3% | +94.0% |
| FY2024 | -71.3% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026